Pam Cheng
EVP, Global Operations, IT & Chief Sustainability OfficerAstraZeneca
PharmaceuticalsView Profile →Executive Vice President, Global Manufacturing & Supply · Novo Nordisk
Kasper Bødker Mejlvang leads Novo Nordisk’s global manufacturing and supply, following production-site leadership and commercial management in Denmark and Japan.
Last reviewed: Nov 15, 2026
Kasper Bødker Mejlvang leads Novo Nordisk’s global manufacturing and supply, following production-site leadership and commercial management in Denmark and Japan.
Mejlvang joined Novo Nordisk in 2002, initially working in global human resources before moving into business support for manufacturing. He also spent three years as a vice president in research and development, supporting the company’s CMC Development organisation.
His subsequent production leadership included insulin active-ingredient manufacturing from 2008 to 2010 and Product Supply Global Support from 2010 to 2013. From 2013 to 2018, he led the fill-finish production site in Chartres, France, overseeing a site turnaround and expansion.
In 2019, he moved into commercial operations as general manager for Denmark and Iceland. He became president and representative director of Novo Nordisk Pharma in Japan in September 2022. While in Japan, he also undertook pharmaceutical-industry association work, including appointment as an EFPIA Japan vice-chair for a term beginning in 2024.
On January 1, 2026, Mejlvang became executive vice president for global manufacturing and supply. The move returned him to worldwide production leadership after his country-management assignments. He holds master’s degrees in management from Bath and psychology from Copenhagen, as well as an executive MBA from IMD.